Skip to content
Announcement: Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
Blog Post: Engineering CAR T-Cells to Function Where Others Fail
Logo
Generate:Biomedicines Logo
  • Generative Biology®
  • The Generate Platform™
  • Pipeline
  • About Us
  • Careers
  • Media Center
  • Investors
Generate:Biomedicines Logo
  • Generative Biology®
  • The Generate Platform™
  • Pipeline
  • About Us
  • Careers
  • Media Center
  • Investors
  • LinkedIn
  • X
  • YouTube
Generate:Biomedicines Flagship Logo

Media Center

  • Overview
  • Blog Posts
  • Media Highlights
  • News Releases
  • Presentations & Publications

Get the latest updates from our team on new research, thought leadership, and company news and events.

Blog Posts

See All

Oct 01, 2026
Blog Posts

Engineering CAR T-Cells to Function Where Others Fail

Read More
Aug 07, 2026
Blog Posts

Designing Beyond Tolerability Limits: Advancing GB-4362 Into Clinical Development 

Read More

Media Highlights

See All

Sep 13, 2026
Media Highlights

Next in Medicine

View on Boston Globe
Sep 08, 2026
Media Highlights

Best Workplaces for Innovators 2026: Technology and science category winners

View on Fast Company

News Releases

See All

Oct 01, 2026
News Releases

Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer

Read More
Sep 08, 2026
News Releases

Generate Biomedicines Inc. to Participate in September Investor Conferences 

Read More

Presentations & Publications

See All

Sep 08, 2026
Presentations & Publications

GB-0895 SOLAIRIA-1 & SOLAIRIA-2 ERS Barcelona 2026 Final

Read More

Now we can.

Contact Us

Generate:Biomedicines
101 South Street, Suite 900
Somerville, MA 02143
United States

© 2026 Generate:Biomedicines

  • LinkedIn
  • X
  • YouTube
  • Privacy Policy
  • Terms of Use
  • Cookie Settings